To: Mike M who wrote (8672 ) 2/6/2003 5:39:01 PM From: Bill Wexler Read Replies (1) | Respond to of 10293 The problem with you Moron, is that you assume that the people reading this thread can't read a simple income statement. Here is the hype:biz.yahoo.com Here is the reality: --------------------- Certain information is set forth below for our Zicam operations expressed in dollars and as a percentage of net sales for the periods indicated: THREE MONTHS ENDED MARCH 31, --------------------------------------- 2002 2001 ------------------ ------------------ Net sales $5,067,511 100% $6,472,190 100% Cost of sales 1,247,236 25 1,613,320 25 ---------- ---- ---------- ---- Gross profit 3,820,275 75 4,858,870 75 Operating expenses 2,881,049 57 4,465,096 69 Research and development 26,545 0 51,602 1 ---------- ---- ---------- ---- Income from operations 912,681 18 342,172 5 Interest and other income 113,693 2 27,983 -- Interest expense 182,213 3 25,512 -- ---------- ---- ---------- ---- Income before income taxes and minority interest $ 844,161 17% $ 344,643 5% ========== ==== ========== ==== NET SALES. Net Zicam sales for the three months ended March 31, 2002 decreased to approximately $5.1 million or 22% below the same period of the previous year. Approximately 70% of the sales in each period related to Zicam Cold Remedy and the remainder to Zicam Allergy Relief. Decreases in sales for both products contributed to the decline in sales for the two periods. The decline in sales for our products primarily resulted from a very weak cold season industry-wide during the first quarter of 2002 compared to a relatively strong cold season for the same period in the prior year. In response to the weak market, we adjusted our advertising strategy for 2002 to reduce our expenditures in the first quarter to conserve resources for later in the year.